Prosecution Insights
Prosecution Insights
4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 3 (75%) |
| Double-patenting + other | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GURLEY, JAMI MICHELLE | 1 | 50.0% | +19.3% |
| GODDARD, LAURA B | 1 | 50.9% | +14.1% |
| HOPKINS, SAMANTHA LAKE | 1 | 56.8% | +67.9% |
| SAOUD, CHRISTINE J | 1 | 58.0% | +37.7% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18684660 | Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use Thereof | GURLEY, JAMI MICHELLE | — |
| 18580552 | ANTI-CLL-1 ANTIBODIES AND USES THEREOF | GODDARD, LAURA B | — |
| 18209299 | ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN ROR1 AND USE FOR THE SAME | HOPKINS, SAMANTHA LAKE | — |
| 17616799 | BISPECIFIC ANTIBODY AGAINST Alpha-SYNUCLEIN AND INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF1R) AND COMPOSITIONS AND USES THEREOF | SAOUD, CHRISTINE J | — |
| Art Unit | Apps |
|---|---|
| 1641 | 1 |
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18684660 | Anti-B7-H4/Anti-4-1BB Bispecific Antibodies And Use Thereof | GURLEY, JAMI MICHELLE | — | §112 | Non-Final OA | — | Pending | Feb 17, 2024 |
| 18580552 | ANTI-CLL-1 ANTIBODIES AND USES THEREOF | GODDARD, LAURA B | — | §112 | Non-Final OA | — | Pending | Jan 18, 2024 |
| 18209299 | ANTIBODY-DRUG CONJUGATE COMPRISING ANTIBODY AGAINST HUMAN ROR1 AND USE FOR THE SAME | HOPKINS, SAMANTHA LAKE | 1641 | §112DP | Non-Final OA | — | Pending | Jun 13, 2023 |
| 17616799 | BISPECIFIC ANTIBODY AGAINST Alpha-SYNUCLEIN AND INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR (IGF1R) AND COMPOSITIONS AND USES THEREOF | SAOUD, CHRISTINE J | 1645 | §112 | Non-Final OA | — | Pending | Dec 06, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial